Febulife 40mg Tablet contains Febuxostat, a xanthine oxidase inhibitor used primarily to manage hyperuricemia in patients with gout. By selectively inhibiting the enzyme xanthine oxidase, Febuxostat reduces the production of uric acid, thereby lowering serum urate levels and preventing the formation of urate crystals that cause painful gout attacks. This medication is typically prescribed for adults who have not responded adequately to other urate-lowering therapies or who are intolerant to allopurinol. Febulife 40mg is taken orally, usually once daily, with or without food, and the dosage may be adjusted based on the patient's serum uric acid levels and clinical response. It is important to maintain adequate hydration while on this medication to help prevent kidney stones. Common side effects may include nausea, joint pain, rash, and liver function abnormalities, so regular monitoring of liver enzymes and kidney function is recommended during treatment. Febulife should be used cautiously in patients with cardiovascular disease or liver impairment. Patients are advised to inform their healthcare provider of any other medications they are taking to avoid potential drug interactions. Overall, Febulife 40mg Tablet is an effective option for long-term management of gout by controlling uric acid levels and reducing the frequency of gout flares.

Dosage & How to Use